INS and metabolic dysfunction-associated steatohepatitis: Furthermore, expression and activation of SREBP1c is upregulated in the livers of NASH patients [32,33], suggesting that impaired hepatic insulin signaling, and TG accumulation play pivotal roles in disease initiation and progression.